Phoenix Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Buy |
+2,440
| New | +$1.09M | 0.01% | 228 |
|
2025
Q1 | – | Sell |
-2,025
| Closed | -$816K | – | 409 |
|
2024
Q4 | $816K | Sell |
2,025
-256
| -11% | -$103K | 0.01% | 235 |
|
2024
Q3 | $1.06M | Sell |
2,281
-2,208
| -49% | -$1.03M | 0.02% | 215 |
|
2024
Q2 | $2.11M | Sell |
4,489
-548
| -11% | -$257K | 0.03% | 181 |
|
2024
Q1 | $2.1M | Buy |
5,037
+3,467
| +221% | +$1.45M | 0.03% | 184 |
|
2023
Q4 | $668K | Buy |
+1,570
| New | +$668K | 0.01% | 229 |
|
2022
Q4 | – | Sell |
-2,726
| Closed | -$806K | – | 338 |
|
2022
Q3 | $806K | Sell |
2,726
-990
| -27% | -$293K | 0.02% | 206 |
|
2022
Q2 | $1.03M | Sell |
3,716
-4,944
| -57% | -$1.37M | 0.02% | 206 |
|
2022
Q1 | $2.23M | Sell |
8,660
-2,382
| -22% | -$613K | 0.04% | 177 |
|
2021
Q4 | $2.47M | Sell |
11,042
-1,260
| -10% | -$282K | 0.04% | 176 |
|
2021
Q3 | $2.24M | Buy |
12,302
+1,506
| +14% | +$274K | 0.04% | 189 |
|
2021
Q2 | $2.12M | Buy |
10,796
+1,900
| +21% | +$373K | 0.04% | 205 |
|
2021
Q1 | $1.9M | Buy |
+8,896
| New | +$1.9M | 0.04% | 235 |
|